CorWave SA
29 rue du Faubourg Saint-Jacques
Paris
75014
France
Tel: 33-0-1-80-49-19-30
Website: http://www.corwave.fr/
Email: contact@corwave.com
About CorWave SA
CorWave develops blood pumps based on a unique and patented wave membrane pumping technology.YEAR FOUNDED:
2011
LEADERSHIP:
CEO: Louis de Lillers
CTO: Carl Botterbusch
JOBS:
Please click here for CorWave job opportunities.
PRODUCTS:
All Products
FOLLOW CROWAVE:
Tweets by CorWave
12 articles about CorWave SA
-
CorWave Announces the Appointment of Fairuz Hasni as Vice President Human Resources
12/5/2023
CorWave, a French company that develops and manufactures innovative cardiac assist devices, announces the appointment of Fairuz Hasni as Vice President Human Resources.
-
CorWave Announces the Grand Opening of Its Manufacturing Facility on the Banks of the Seine, next to Paris
10/9/2023
CorWave, a French company that develops and manufactures innovative cardiac assist devices, held the grand opening of its new facility on the banks of the Seine in Clichy, next to Paris, on Monday, October 9th.
-
CorWave Announces Second Closing of Its Series C Funding at €61M to Finance Its First Industrial Deployment
6/20/2023
CorWave raised 61 million euros to fund its first industrial deployment and entry into clinical trials.
-
CorWave Attracts Global Talent, Strengthening Its Management Team in Preparation for Clinical Phase and Industrial Ramp Up
9/21/2021
CorWave, a French medtech developing a next-generation heart pump, is recruiting top talent from throughout the world to strengthen its team.
-
CorWave Successfully Performed a 90-Day In Vivo Study on Its Revolutionary Cardiac Pump Synchronized With the Native Heart, Results Presented at ASAIO Meeting
6/14/2021
CorWave Successfully Performed a 90-Day In Vivo Study on Its Revolutionary Cardiac Pump Synchronized With the Native Heart, Results Presented at ASAIO Meeting.
-
CorWave Raises $40 Million in Series C Funding for Its Breakthrough Heart Pump
1/6/2021
CorWave reported today it has raised $40M from returning investors and three new investors. The company is developing an implantable heart pump (Left Ventricular Assist Device, LVAD) based on a breakthrough technology: the wave membrane pump . These new funds will enable CorWave to finalize development of its initial product, expand a manufacturing infrastructure, complete regulatory testing required to conduct human
-
CorWave Reports Two Critical Technical Milestones Required to Proceed to the Clinical Phase at the American Society for Artificial Internal Organs Annual Meeting
6/10/2020
The presentation was selected as Top Bioengineering Abstract and confirms CorWave's commitment to scientific excellence, which enabled demonstration of its Left Ventricular Assist Device’s (LVAD) capability to provide durable, long-term circulatory support with high-fidelity physiologic flow CLICHY, France--( BUSINESS WIRE )-- CorWave announced today that the latest results of its preclinical Left Ventricular Assist Device (LVAD) development program
-
CorWave Appoints Jim Schuermann as an Independent Director
2/11/2020
Feb. 11, 2020 15:00 UTC Medtech industry veteran of two IPOs on the Nasdaq Stock Market (HeartWare, Avedro) CLICHY, France--( BUSINESS WIRE )-- CorWave, a medtech company focused on the development of an innovative Left Ventricular Assist Device (LVAD) to treat patients suffering from severe heart failure, announced today the election of Jim Schuermann to its board of directors. Schuermann was instrumental in transforming HeartWare, an LVAD start-up valued around $10
-
CorWave Presented First Successful In Vivo 60-Day Study on Its Innovative LVAD Cardiac Support Device
9/11/2019
CorWave announced that it successfully completed its first 60-day preclinical study to evaluate its Left Ventricular Assist Device (LVAD).
-
CorWave’s Next-Generation LVAD, Neptune, Receives Funding
7/10/2018
The CALYPSO program will receive 14 million euros to develop CorWave Neptune, a new type of cardiac support to improve the management of patients with severe heart failure, as part of the Programme d’Investissements d’Avenir (PIA) operated by Bpifrance.
-
CorWave Receives 2017 Deloitte 'Technology Fast 50 Biotech of the Future' Award of the Parisian Region
11/10/2017
CorWave announced today that it received the 'Deloitte In Extenso Technology Fast 50 Biotech of the Future' award for the Parisian Region which rewards the outstanding contribution of technology companies to economic growth.
-
CorWave Bags $17.1 Million Series B
11/4/2016